Developer docs
API playgroundTry for free, no card

Search company profiles

Empire City Laboratories

Full company profile

uuid000bomb

Namestring
Empire City Laboratories
Legal namestring
Empire City Laboratories
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Empire City Laboratories was a Brooklyn-headquartered clinical laboratory business that provided routine and specialty diagnostic testing services to patients, healthcare providers, hospitals, and clinicians across the New York Tri-State area. The company operated a network of patient service centers (PSCs) where specimens were collected for centralized laboratory analysis, serving both individual consumers and institutional healthcare clients including health systems and physician practices.

The company's core offering was clinical laboratory testing services—routine and specialty diagnostics—delivered through its PSC network and in-house laboratory capacity. Underlying technology consisted of standard clinical lab instrumentation and workflows integrated with electronic health records and patient/provider portals (Wellcom platform), with no proprietary AI/ML components disclosed. The product set was narrowly focused: a single-offering diagnostic testing business rather than a multi-product platform, and all assets were transferred to Labcorp in February 2026.

Empire City generated revenue through fee-for-service diagnostic testing billed to patients, payors, and healthcare providers. The go-to-market was enterprise field sales combined with distributed PSC volume, serving healthcare providers (hospitals, clinicians, health systems) as the primary vertical and individual patients as a horizontal segment. Approximately 224 employees supported operations prior to the Labcorp acquisition, which closed February 9, 2026 for $165 million upfront plus up to $85 million in contingent milestones. Upon closing, Labcorp secured a multi-year agreement making it the clinically integrated laboratory provider for Somos, a New York provider network covering over one million members.

Short descriptiontext

Empire City Laboratories was a Brooklyn-based clinical laboratory providing routine and specialty diagnostic testing through patient service centers in the New York Tri-State area, serving healthcare providers, hospitals, clinicians, and individual patients until its February 2026 acquisition by Labcorp.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBrooklyn, United States
HQ citystring
Brooklyn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, diagnostic testing services, patient service centers, medical laboratory testing, routine and specialty diagnostics
Industry1 code
1Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryYes
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Testing Services
TypeTransaction Fee
Description

Fee-for-service clinical laboratory testing services provided to patients, healthcare providers, hospitals, and clinicians through patient service centers in the New York Tri-State area. Revenue generated from diagnostic testing procedures and laboratory services.

healthcaredive.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Empire City Laboratories was a clinical laboratory business providing routine and specialty diagnostic testing services to patients, healthcare providers, hospitals, and clinicians in the New York Tri-State area. The company operated patient service centers (PSCs) for specimen collection and laboratory testing, and supported providers through the Wellcom platform for test ordering and results. Following acquisition by Labcorp in February 2026, the operations were integrated into Labcorp's national diagnostic testing network.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Empire City Laboratories was a single-offering clinical laboratory business providing patient service centers (PSCs) and clinical laboratory testing services in the New York Tri-State area. The company operated as a focused diagnostic testing service rather than a platform with multiple distinct products. All operations were acquired by Labcorp in February 2026.

Product and service2 records
1Clinical Laboratory Testing Services
CategoryClinical Laboratory Services
Description

Comprehensive clinical laboratory testing services including routine and specialty diagnostic tests, offered to patients, healthcare providers, hospitals, and clinicians throughout the New York Tri-State area. Specimens are collected at patient service centers and analyzed at clinical laboratory assets.

2Patient Service Centers (PSCs)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Following Labcorp's acquisition of Empire City Laboratories assets, Labcorp entered into a multi-year agreement with Somos, a network of New York healthcare providers serving over one million people. Under this agreement, Labcorp serves as Somos's clinically integrated laboratory provider of choice.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The largest U.S. clinical laboratory operator, directly comparable to Empire City as a national provider of routine and specialty diagnostic testing through patient service centers and hospital/health system partnerships.

TypeDirect peer
Description

A regional clinical laboratory providing routine and specialty diagnostic testing across the U.S. Northeast, directly comparable to Empire City's model of regional PSC-based specimen collection and clinical diagnostics.

TypeDirect peer
Description

An international clinical laboratory operator with U.S. operations providing routine and esoteric testing via patient service centers, overlapping directly with Empire City's fee-for-service clinical diagnostics model.

TypeDirect peer
Description

A New York-area clinical laboratory providing routine and specialty testing with courier collection and patient service center access, directly comparable to Empire City on regional footprint and service mix.

TypeDirect peer
Description

A New York-metro clinical laboratory offering routine and specialty diagnostic testing for physicians, hospitals, and patients, closely mirroring Empire City's regional PSC-and-lab-service operating model.

TypeDirect peer
Description

A Northeast U.S.-based clinical laboratory providing diagnostic testing services to physicians and patients, comparable to Empire City on regional clinical lab operations and provider relationships.

TypeBroad incumbent
Description

A national reference and esoteric clinical laboratory affiliated with the University of Utah, broadly comparable to Empire City's specialty testing capability but operating at much larger scale and broader geographic reach.

TypeBroad incumbent
Description

A large academic reference laboratory offering specialty and esoteric testing nationwide, comparable to Empire City on the diagnostic testing category but materially broader in scope and test menu.

TypeRegional player
Description

The in-house clinical laboratory arm of a large New York-area health system, providing routine and specialty diagnostic testing to affiliated hospitals and providers in the same metro where Empire City operated.

TypeEmerging player
Description

A specialty clinical laboratory focused on toxicology, pharmacogenomics, and infectious disease testing, comparable as an emerging regional/specialty diagnostic testing platform overlapping with Empire City's clinical lab category.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Empire City Laboratories

Clinical Laboratory Servicesempirecitylabs.com

Empire City Laboratories was a Brooklyn-based clinical laboratory providing routine and specialty diagnostic testing through patient service centers in the New York Tri-State area, serving healthcare providers, hospitals, clinicians, and individual patients until its February 2026 acquisition by Labcorp.

What Empire City Laboratories does

Empire City Laboratories was a Brooklyn-headquartered clinical laboratory business that provided routine and specialty diagnostic testing services to patients, healthcare providers, hospitals, and clinicians across the New York Tri-State area. The company operated a network of patient service centers (PSCs) where specimens were collected for centralized laboratory analysis, serving both individual consumers and institutional healthcare clients including health systems and physician practices.

The company's core offering was clinical laboratory testing services—routine and specialty diagnostics—delivered through its PSC network and in-house laboratory capacity. Underlying technology consisted of standard clinical lab instrumentation and workflows integrated with electronic health records and patient/provider portals (Wellcom platform), with no proprietary AI/ML components disclosed. The product set was narrowly focused: a single-offering diagnostic testing business rather than a multi-product platform, and all assets were transferred to Labcorp in February 2026.

Empire City generated revenue through fee-for-service diagnostic testing billed to patients, payors, and healthcare providers. The go-to-market was enterprise field sales combined with distributed PSC volume, serving healthcare providers (hospitals, clinicians, health systems) as the primary vertical and individual patients as a horizontal segment. Approximately 224 employees supported operations prior to the Labcorp acquisition, which closed February 9, 2026 for $165 million upfront plus up to $85 million in contingent milestones. Upon closing, Labcorp secured a multi-year agreement making it the clinically integrated laboratory provider for Somos, a New York provider network covering over one million members.

Empire City Laboratories firmographics

Firmographics
Name
Empire City Laboratories
Legal name
Empire City Laboratories
Website
https://empirecitylabs.com
Company type
Private
Founded year
2008
Operating status
Acquired
Headcount range
251–500 employees
Short description
Empire City Laboratories was a Brooklyn-based clinical laboratory providing routine and specialty diagnostic testing through patient service centers in the New York Tri-State area, serving healthcare providers, hospitals, clinicians, and individual patients until its February 2026 acquisition by Labcorp.
Ownership category
akta.pro rank

Empire City Laboratories industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

  • Clinical laboratory services
  • Diagnostic testing services
  • Patient service centers
  • Medical laboratory testing
  • Routine and specialty diagnostics

Where Empire City Laboratories is headquartered

Location

Headquarters

HQ city
Brooklyn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Empire City Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Clinical Laboratory Testing Services: Fee-for-service clinical laboratory testing services provided to patients, healthcare providers, hospitals, and clinicians through patient service centers in the New York Tri-State area. Revenue generated from diagnostic testing procedures and laboratory services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Empire City Laboratories product offering

Product offering

Core offering

Empire City Laboratories was a clinical laboratory business providing routine and specialty diagnostic testing services to patients, healthcare providers, hospitals, and clinicians in the New York Tri-State area. The company operated patient service centers (PSCs) for specimen collection and laboratory testing, and supported providers through the Wellcom platform for test ordering and results. Following acquisition by Labcorp in February 2026, the operations were integrated into Labcorp's national diagnostic testing network.

Product overview

Empire City Laboratories was a single-offering clinical laboratory business providing patient service centers (PSCs) and clinical laboratory testing services in the New York Tri-State area. The company operated as a focused diagnostic testing service rather than a platform with multiple distinct products. All operations were acquired by Labcorp in February 2026.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Laboratory Testing Services Comprehensive clinical laboratory testing services including routine and specialty diagnostic tests, offered to patients, healthcare providers, hospitals, and clinicians throughout the New York Tri-State area. Specimens are collected at patient service centers and analyzed at clinical laboratory assets.
  • Patient Service Centers (PSCs)

Companies that use Empire City Laboratories

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Empire City Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Empire City Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SomoscoreStrategic or Co-development Partner · 11 February 2026Following Labcorp's acquisition of Empire City Laboratories assets, Labcorp entered into a multi-year agreement with Somos, a network of New York healthcare providers serving over one million people. Under this agreement, Labcorp serves as Somos's clinically integrated laboratory provider of choice.

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Empire City Laboratories competitors and assessment

Company assessment

Direct peers

  • Quest Diagnostics: The largest U.S. clinical laboratory operator, directly comparable to Empire City as a national provider of routine and specialty diagnostic testing through patient service centers and hospital/health system partnerships.
  • BioReference Laboratories: A regional clinical laboratory providing routine and specialty diagnostic testing across the U.S. Northeast, directly comparable to Empire City's model of regional PSC-based specimen collection and clinical diagnostics.
  • Sonic Healthcare USA: An international clinical laboratory operator with U.S. operations providing routine and esoteric testing via patient service centers, overlapping directly with Empire City's fee-for-service clinical diagnostics model.
  • Sunrise Medical Laboratories: A New York-area clinical laboratory providing routine and specialty testing with courier collection and patient service center access, directly comparable to Empire City on regional footprint and service mix.
  • Enzo Clinical Labs: A New York-metro clinical laboratory offering routine and specialty diagnostic testing for physicians, hospitals, and patients, closely mirroring Empire City's regional PSC-and-lab-service operating model.
  • ACM Medical Laboratory: A Northeast U.S.-based clinical laboratory providing diagnostic testing services to physicians and patients, comparable to Empire City on regional clinical lab operations and provider relationships.

Broad incumbents

  • ARUP Laboratories: A national reference and esoteric clinical laboratory affiliated with the University of Utah, broadly comparable to Empire City's specialty testing capability but operating at much larger scale and broader geographic reach.
  • Mayo Clinic Laboratories: A large academic reference laboratory offering specialty and esoteric testing nationwide, comparable to Empire City on the diagnostic testing category but materially broader in scope and test menu.

Regional players

  • Northwell Health Laboratories: The in-house clinical laboratory arm of a large New York-area health system, providing routine and specialty diagnostic testing to affiliated hospitals and providers in the same metro where Empire City operated.

Emerging players

  • Aegis Sciences Corporation: A specialty clinical laboratory focused on toxicology, pharmacogenomics, and infectious disease testing, comparable as an emerging regional/specialty diagnostic testing platform overlapping with Empire City's clinical lab category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Empire City Laboratories social profiles

Digital presence

Empire City Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Empire City Laboratories leadership team

Management profile

Number of profiles

Empire City Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Empire City Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Empire City Laboratories

What does Empire City Laboratories do?

Empire City Laboratories was a clinical laboratory business providing routine and specialty diagnostic testing services to patients, healthcare providers, hospitals, and clinicians in the New York Tri-State area. The company operated patient service centers (PSCs) for specimen collection and laboratory testing, and supported providers through the Wellcom platform for test ordering and results. Following acquisition by Labcorp in February 2026, the operations were integrated into Labcorp's national diagnostic testing network.

Is Empire City Laboratories a public or private company?

Empire City Laboratories is a private company. It is classified as corporate owned and is currently acquired.

When was Empire City Laboratories founded?

Empire City Laboratories was founded in 2008. It employs 251 to 500 people.

Where is Empire City Laboratories based?

Empire City Laboratories is headquartered in Brooklyn, United States, in the North America region.

How does Empire City Laboratories make money?

One revenue line is on record: clinical Laboratory Testing Services.

Who are Empire City Laboratories's main competitors?

Direct peers on record are Quest Diagnostics, BioReference Laboratories, Sonic Healthcare USA, Sunrise Medical Laboratories, Enzo Clinical Labs and ACM Medical Laboratory. Broad incumbents are ARUP Laboratories and Mayo Clinic Laboratories. Northwell Health Laboratories is listed as a regional player. Aegis Sciences Corporation is listed as an emerging player.

Does Empire City Laboratories have an API?

No public API is recorded for Empire City Laboratories.

What industry is Empire City Laboratories in?

Empire City Laboratories's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals